{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T03:31:51Z","timestamp":1793935911093,"version":"4.8.0"},"reference-count":304,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010607","name":"Universit\u00e0 degli Studi di Perugia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.plipres.2026.101380","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:25:50Z","timestamp":1772781950000},"page":"101380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Nutrigenomics of fat-soluble vitamins and micronutrients in hepatocyte lipotoxicity and MASLD"],"prefix":"10.1016","volume":"101","author":[{"given":"Anna","family":"Migni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rachele","family":"Ceccarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Cavaliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Garetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Lucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0010","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/TP.0000000000002484","article-title":"Epidemiology of nonalcoholic fatty liver disease and nonalcoholic Steatohepatitis: implications for liver transplantation","volume":"103","author":"Younossi","year":"2019","journal-title":"Transplantation"},{"issue":"Suppl. 1","key":"10.1016\/j.plipres.2026.101380_bb0020","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0025","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","article-title":"From NASH to diabetes and from diabetes to NASH: mechanisms and treatment options","volume":"1","author":"Gastaldelli","year":"2019","journal-title":"JHEP Rep"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb0030","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb0035","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb0040","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"(EASL), E.A.f.t.S.o.t.L., E.A.f.t.S.o.D. (EASD), and E.A.f.t.S.o.O. (EASO)","year":"2024","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2025.101903","article-title":"Updated recommendations for the management of metabolic dysfunction-associated steatotic liver disease (MASLD) by the Latin American working group","volume":"30","author":"Diaz","year":"2025","journal-title":"Ann Hepatol"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0050","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0055","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.31518","article-title":"Multiple parallel hits hypothesis in nonalcoholic fatty liver disease: revisited after a decade","volume":"73","author":"Tilg","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2026.101380_bb0060","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"10464","key":"10.1016\/j.plipres.2026.101380_bb0065","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0070","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/s41423-025-01307-5","article-title":"Immunopathogenic mechanisms and immunoregulatory therapies in MASLD","volume":"22","author":"He","year":"2025","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb0075","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, Randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0080","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/d41573-024-00051-1","article-title":"NASH field celebrates 'hurrah moment' with a first FDA drug approval for the liver disease","volume":"23","author":"Kingwell","year":"2024","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0085","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0090","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26041778","article-title":"Current therapeutic landscape for metabolic dysfunction-associated steatohepatitis","volume":"26","author":"Devasia","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27325","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease: current status and future perspective","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.plipres.2026.101380_bb0100","doi-asserted-by":"crossref","first-page":"1652996","DOI":"10.3389\/fendo.2025.1652996","article-title":"A new perspective on non-invasive diagnosis of non- alcoholic fatty liver disease: evidence integration of inflammatory and metabolic biomarkers based on a scoping review","volume":"16","author":"Liang","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0105","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2468-1253(23)00017-1","article-title":"Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study","volume":"8","author":"Vali","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0110","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1172\/JCI81507","article-title":"Abdominal obesity: a marker of ectopic fat accumulation","volume":"125","author":"Smith","year":"2015","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.plipres.2026.101380_bb0115","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1038\/oby.2011.114","article-title":"Predictors of ectopic fat accumulation in liver and pancreas in obese men and women","volume":"19","author":"Rossi","year":"2011","journal-title":"Obesity (Silver Spring)"},{"issue":"24","key":"10.1016\/j.plipres.2026.101380_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413238","article-title":"The causal role of ectopic fat deposition in the pathogenesis of metabolic syndrome","volume":"25","author":"Janssen","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0125","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1080\/14779072.2016.1256773","article-title":"Ectopic fat: a target for cardiometabolic risk management","volume":"14","author":"Gastaldelli","year":"2016","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0130","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0135","article-title":"Lipid metabolism in MASLD and MASH: from mechanism to the clinic","volume":"6","author":"Carli","year":"2024","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0140","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0030-1267538","article-title":"The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis","volume":"30","author":"Sozio","year":"2010","journal-title":"Semin Liver Dis"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb0145","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/liv.15377","article-title":"Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals","volume":"42","author":"Saponaro","year":"2022","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105511","article-title":"Adipose tissue plasticity in response to pathophysiological cues: a connecting link between obesity and its associated comorbidities","volume":"23","author":"De Fano","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"23","key":"10.1016\/j.plipres.2026.101380_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242316645","article-title":"Accumulation of 4-hydroxynonenal characterizes diabetic fat and modulates adipogenic differentiation of adipose precursor cells","volume":"24","author":"Murdolo","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb0160","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.cmet.2023.10.008","article-title":"The PNPLA3 I148M variant increases ketogenesis and decreases hepatic de novo lipogenesis and mitochondrial function in humans","volume":"35","author":"Luukkonen","year":"2023","journal-title":"Cell Metab"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0165","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/hep4.2053","article-title":"Reduction in gut-derived MUFAs via intestinal stearoyl-CoA desaturase 1 deletion drives susceptibility to NAFLD and hepatocarcinoma","volume":"6","author":"Ducheix","year":"2022","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb0170","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","article-title":"Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease","volume":"76","author":"Luukkonen","year":"2022","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0175","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","article-title":"Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma","volume":"74","author":"Ha","year":"2024","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0185","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1093\/ibd\/izad175","article-title":"Inflammatory bowel disease is an independent risk factor for metabolic dysfunction-associated steatotic liver disease in lean individuals","volume":"30","author":"Mart\u00ednez-Dom\u00ednguez","year":"2024","journal-title":"Inflamm Bowel Dis"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb0190","article-title":"Prevalence of non-alcoholic fatty liver disease in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"17","author":"Postoev","year":"2025","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0195","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.180943","article-title":"Circulating metabolite signatures indicate differential gut-liver crosstalk in lean and obese MASLD","volume":"10","author":"Haag","year":"2025","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0200","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/gutjnl-2024-332602","article-title":"Multiomics of the intestine-liver-adipose axis in multiple studies unveils a consistent link of the gut microbiota and the antiviral response with systemic glucose metabolism","volume":"74","author":"Castells-Nobau","year":"2025","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0205","article-title":"Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases","volume":"6","author":"Garc\u00eda-Nieto","year":"2024","journal-title":"JHEP Rep"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0210","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0041-1730927","article-title":"Insights into nonalcoholic fatty-liver disease heterogeneity","volume":"41","author":"Arrese","year":"2021","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0215","doi-asserted-by":"crossref","DOI":"10.1080\/19420889.2016.1183854","article-title":"Spatial distribution of lipid droplets during starvation: implications for lipophagy","volume":"9","author":"Barbosa","year":"2016","journal-title":"Commun Integr Biol"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0220","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbalip.2018.05.002","article-title":"Long-chain metabolites of vitamin E: interference with lipotoxicity via lipid droplet associated protein PLIN2","volume":"1863","author":"Schmolz","year":"2018","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb0225","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1073\/pnas.0630588100","article-title":"Triglyceride accumulation protects against fatty acid-induced lipotoxicity","volume":"100","author":"Listenberger","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0230","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.ajpath.2023.08.007","article-title":"The role of endoplasmic reticulum in lipotoxicity during metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis","volume":"193","author":"Venkatesan","year":"2023","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0235","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.bbalip.2018.05.002","article-title":"Long-chain metabolites of vitamin E: interference with lipotoxicity via lipid droplet associated protein PLIN2","volume":"1863","author":"Schm\u00f6lz","year":"2018","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0240","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0245","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","volume":"76","author":"Moore","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2026.101380_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.657389","article-title":"Autophagy in hepatic steatosis: a structured review","volume":"9","author":"Ramos","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0255","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI82204","article-title":"Mitochondrial metabolism mediates oxidative stress and inflammation in fatty liver","volume":"125","author":"Satapati","year":"2015","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb0260","article-title":"Integrating the contributions of mitochondrial oxidative metabolism to lipotoxicity and inflammation in NAFLD pathogenesis","volume":"1867","author":"Hughey","year":"2022","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0265","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb0275","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.acthis.2018.02.005","article-title":"Tetrazolium salts and formazan products in cell biology: viability assessment, fluorescence imaging, and labeling perspectives","volume":"120","author":"Stockert","year":"2018","journal-title":"Acta Histochem"},{"key":"10.1016\/j.plipres.2026.101380_bb0290","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0295","doi-asserted-by":"crossref","first-page":"939","DOI":"10.14218\/JCTH.2022.00067","article-title":"Reactive oxygen species and oxidative stress in the pathogenesis of MAFLD","volume":"10","author":"Clare","year":"2022","journal-title":"J Clin Transl Hepatol"},{"issue":"7814","key":"10.1016\/j.plipres.2026.101380_bb0300","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-020-2337-2","article-title":"Hepatic NADH reductive stress underlies common variation in metabolic traits","volume":"583","author":"Goodman","year":"2020","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0305","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41589-022-01004-8","article-title":"Why succinate? Physiological regulation by a mitochondrial coenzyme Q sentinel","volume":"18","author":"Murphy","year":"2022","journal-title":"Nat Chem Biol"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb0310","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s13679-022-00473-1","article-title":"Hepatocyte mitochondrial dynamics and bioenergetics in obesity-related non-alcoholic fatty liver disease","volume":"11","author":"Legaki","year":"2022","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.plipres.2026.101380_bb0315","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.redox.2016.12.035","article-title":"Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress","volume":"11","author":"Sies","year":"2017","journal-title":"Redox Biol"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb0320","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb0325","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/s41580-022-00456-z","article-title":"Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology","volume":"23","author":"Sies","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.plipres.2026.101380_bb0330","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.trsl.2017.11.007","article-title":"Nrf2-p62 autophagy pathway and its response to oxidative stress in hepatocellular carcinoma","volume":"193","author":"Bartolini","year":"2018","journal-title":"Transl Res"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0335","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s43856-025-00780-3","article-title":"Deep proteome profiling of metabolic dysfunction-associated steatotic liver disease","volume":"5","author":"Boel","year":"2025","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.plipres.2026.101380_bb0280","doi-asserted-by":"crossref","first-page":"109319","DOI":"10.1016\/j.jnutbio.2023.109319","article-title":"Transcriptomics of natural and synthetic vitamin D in human hepatocyte lipotoxicity","volume":"117","author":"Bartolini","year":"2023","journal-title":"J Nutr Biochem"},{"issue":"9","key":"10.1016\/j.plipres.2026.101380_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10748","article-title":"Wheat germ oil vitamin E cytoprotective effect and its nutrigenomics signature in human hepatocyte lipotoxicity","volume":"8","author":"Bartolini","year":"2022","journal-title":"Heliyon"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0340","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s42255-021-00489-2","article-title":"Peroxisomal \u03b2-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis","volume":"3","author":"Ding","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/j.plipres.2026.101380_bb0345","series-title":"Increased plasma levels of the lipoperoxyl radical-derived vitamin e metabolite \u0391-tocopheryl quinone are an early indicator of lipotoxicity in fatty liver subjects","first-page":"115","volume":"vol. 131","author":"Torquato","year":"2019"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0350","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12944-020-01210-0","article-title":"Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease","volume":"19","author":"Wang","year":"2020","journal-title":"Lipids Health Dis"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00204-024-03889-x","article-title":"Metabolic dysfunction-associated steatotic liver disease-induced changes in the antioxidant system: a review","volume":"99","author":"Svobodov\u00e1","year":"2025","journal-title":"Arch Toxicol"},{"issue":"9","key":"10.1016\/j.plipres.2026.101380_bb0360","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14229","article-title":"Oxidative stress, defective proteostasis and immunometabolic complications in critically ill patients","volume":"54","author":"Galli","year":"2024","journal-title":"Eur J Clin Investig"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb0365","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002413RR","article-title":"NUPR1 protects liver from lipotoxic injury by improving the endoplasmic reticulum stress response","volume":"35","author":"Teresa Borrello","year":"2021","journal-title":"FASEB J"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0370","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3350\/cmh.2020.0173","article-title":"Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases","volume":"26","author":"Kim","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.plipres.2026.101380_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102235","article-title":"PERK prevents hepatic lipotoxicity by activating the p62-ULK1 axis-mediated noncanonical KEAP1-Nrf2 pathway","volume":"50","author":"Lee","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.plipres.2026.101380_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100073","article-title":"The lipidome in nonalcoholic fatty liver disease: actionable targets","volume":"62","author":"Pirola","year":"2021","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0385","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0390","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0395","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cmet.2006.03.007","article-title":"The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis","volume":"3","author":"Li","year":"2006","journal-title":"Cell Metab"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0400","doi-asserted-by":"crossref","first-page":"436","DOI":"10.4254\/wjh.v12.i8.436","article-title":"Lipidomics in non-alcoholic fatty liver disease","volume":"12","author":"Kartsoli","year":"2020","journal-title":"World J Hepatol"},{"issue":"7348","key":"10.1016\/j.plipres.2026.101380_bb0405","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature09968","article-title":"Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity","volume":"473","author":"Fu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2026.101380_bb0410","doi-asserted-by":"crossref","first-page":"46658","DOI":"10.1038\/srep46658","article-title":"Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients","volume":"7","author":"Chiappini","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/nu10050649","article-title":"Circulating phospholipid patterns in NAFLD patients associated with a combination of metabolic risk factors","volume":"10","author":"Tiwari-Heckler","year":"2018","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.plipres.2026.101380_bb0420","doi-asserted-by":"crossref","DOI":"10.3390\/biom10091275","article-title":"Hepatic Lipidomics and molecular imaging in a murine non-alcoholic fatty liver disease model: insights into molecular mechanisms","volume":"10","author":"Rodr\u00edguez-Calvo","year":"2020","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0425","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0430","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7150\/ijbs.78525","article-title":"Insights into the roles and pathomechanisms of ceramide and sphigosine-1-phosphate in nonalcoholic fatty liver disease","volume":"19","author":"Zhu","year":"2023","journal-title":"Int J Biol Sci"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0435","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/liv.12685","article-title":"Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis","volume":"35","author":"Yamada","year":"2015","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb0440","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.70047","article-title":"Melatonin repairs the lipidome of human hepatocytes exposed to cd and free fatty acid-induced lipotoxicity","volume":"77","author":"Migni","year":"2025","journal-title":"J Pineal Res"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb0445","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1194\/jlr.P056002","article-title":"Biomarkers of NAFLD progression: a lipidomics approach to an epidemic","volume":"56","author":"Gorden","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2026.101380_bb0450","first-page":"1","article-title":"Phospholipid metabolism in innate immunity and inflammation: from basic to clinic","author":"Liu","year":"2025","journal-title":"Immun Inflamm"},{"key":"10.1016\/j.plipres.2026.101380_bb0455","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jnutbio.2017.06.003","article-title":"Nonalcoholic fatty liver disease impairs the cytochrome P-450-dependent metabolism of alpha-tocopherol (vitamin E)","volume":"47","author":"Bartolini","year":"2017","journal-title":"J Nutr Biochem"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0460","doi-asserted-by":"crossref","DOI":"10.3390\/biom13121758","article-title":"Melatonin as a repairing agent in cadmium- and free fatty acid-induced lipotoxicity","volume":"13","author":"Migni","year":"2023","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2023.113655","article-title":"Oleic acid improves hepatic lipotoxicity injury by alleviating autophagy dysfunction","volume":"429","author":"Liu","year":"2023","journal-title":"Exp Cell Res"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb0470","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1093\/jn\/nxz147","article-title":"A Mediterranean diet rich in extra-virgin olive oil is associated with a reduced prevalence of nonalcoholic fatty liver disease in older individuals at high cardiovascular risk","volume":"149","author":"Pint\u00f3","year":"2019","journal-title":"J Nutr"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0475","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ajcnut.2025.02.012","article-title":"Changes in olive oil consumption and long-term body weight changes in 3 United States prospective cohort studies","volume":"121","author":"Guasch-Ferr\u00e9","year":"2025","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.plipres.2026.101380_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101937","article-title":"Impact of vitamin E on redox biomarkers in non-alcoholic fatty liver disease","volume":"42","author":"Podszun","year":"2021","journal-title":"Redox Biol"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0485","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105375","article-title":"Nonalcoholic fatty liver disease (NAFLD). Mitochondria as players and targets of therapies?","volume":"22","author":"Di Ciaula","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0490","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.plipres.2026.101380_bb0495","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.redox.2016.05.003","article-title":"Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration","volume":"9","author":"Carlson","year":"2016","journal-title":"Redox Biol"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0500","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/hep.26238","article-title":"Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease","volume":"57","author":"Maliken","year":"2013","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0505","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/BF02535211","article-title":"Microsomal lipid peroxidation: effect of vitamin E and its functional interaction with phospholipid hydroperoxide glutathione peroxidase","volume":"24","author":"Maiorino","year":"1989","journal-title":"Lipids"},{"key":"10.1016\/j.plipres.2026.101380_bb0510","doi-asserted-by":"crossref","first-page":"1090338","DOI":"10.3389\/fnut.2023.1090338","article-title":"Ferroptosis in non-alcoholic liver disease: molecular mechanisms and therapeutic implications","volume":"10","author":"Cheng","year":"2023","journal-title":"Front Nutr"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb0515","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0520","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic B cells aggravates NASH through innate and adaptive signaling","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0525","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13287-022-02929-6","article-title":"The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles","volume":"13","author":"Moayedfard","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.plipres.2026.101380_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103768","article-title":"Peripheral immune cells in NAFLD patients: a spyhole to disease progression","volume":"75","author":"Lin","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.plipres.2026.101380_bb0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101849","article-title":"Regulated cell death in neutrophils: from apoptosis to NETosis and pyroptosis","volume":"70","author":"Dejas","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/j.plipres.2026.101380_bb0540","article-title":"Active role of the immune system in metabolic dysfunction-associated steatotic liver disease","volume":"12","author":"Mori","year":"2024","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.plipres.2026.101380_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175618","article-title":"Polyunsaturated fatty acids drive neutrophil extracellular trap formation in nonalcoholic steatohepatitis","volume":"945","author":"Wu","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0550","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12263-013-0383-1","article-title":"A case-control study on the effect of metabolic gene polymorphisms, nutrition, and their interaction on the risk of non-alcoholic fatty liver disease","volume":"9","author":"Miele","year":"2014","journal-title":"Genes Nutr"},{"key":"10.1016\/j.plipres.2026.101380_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104620","article-title":"Cross-tissue omics analysis discovers ten adipose genes encoding secreted proteins in obesity-related non-alcoholic fatty liver disease","volume":"92","author":"Darci-Maher","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.plipres.2026.101380_bb0560","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.733197","article-title":"Combined transcriptomic and lipidomic analysis reveals dysregulated genes expression and lipid metabolism profiles in the early stage of fatty liver disease in rats","volume":"8","author":"Zhai","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.plipres.2026.101380_bb0565","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12944-016-0190-y","article-title":"Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study","volume":"15","author":"Yuan","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.plipres.2026.101380_bb0570","first-page":"5","article-title":"A compendium of noncoding RNAs as biomarkers in type 2 diabetes mellitus","author":"Akella","year":"2025","journal-title":"J Pharm Biomed Anal Open"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb0575","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.gendis.2022.05.022","article-title":"Clinical relevance of circulating non-coding RNAs in metabolic diseases: emphasis on obesity, diabetes, cardiovascular diseases and metabolic syndrome","volume":"10","author":"Dandare","year":"2023","journal-title":"Genes Dis"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0580","doi-asserted-by":"crossref","DOI":"10.3390\/livers5020016","article-title":"Comparative analysis of the human proteome profile in visceral adipose and liver tissue in individuals with obesity with and without MASLD and MASH","volume":"5","author":"Pedersen","year":"2025","journal-title":"Liver"},{"key":"10.1016\/j.plipres.2026.101380_bb0585","first-page":"1219","article-title":"Correlation of plasma and liver tissue proteomics for plasma biomarkers in metabolic dysfunction-associated steatotic liver disease","volume":"24","author":"Sourianarayanane","year":"2025","journal-title":"J Proteome Res"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0590","article-title":"Metabolomics at the cutting edge of risk prediction of MASLD","volume":"5","author":"Tan","year":"2024","journal-title":"Cell Rep Med"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0595","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.plipres.2026.101380_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101238","article-title":"Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): recent advances","volume":"91","author":"Musso","year":"2023","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.plipres.2026.101380_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118068","article-title":"Lipidomics reveals different therapeutic potential for natural and synthetic vitamin D formulations in hepatocyte lipotoxicity","volume":"187","author":"Migni","year":"2025","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb0610","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1042\/CS20030326","article-title":"Increase in long-chain polyunsaturated fatty acid n - 6\/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease","volume":"106","author":"Araya","year":"2004","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.plipres.2026.101380_bb0615","doi-asserted-by":"crossref","DOI":"10.1177\/1756284820923904","article-title":"Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitis","volume":"13","author":"Caussy","year":"2020","journal-title":"Ther Adv Gastroenterol"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0620","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1194\/jlr.M007096","article-title":"Mass spectrometric profiling of oxidized lipid products in human nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"51","author":"Feldstein","year":"2010","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.plipres.2026.101380_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25092026","article-title":"Eicosanoids in nonalcoholic fatty liver disease (NAFLD) progression. Do serum eicosanoids profile correspond with liver eicosanoids content during NAFLD development and progression?","volume":"25","author":"Maciejewska","year":"2020","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0630","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/jgh.14654","article-title":"Serum C16:1n7\/C16:0 ratio as a diagnostic marker for non-alcoholic steatohepatitis","volume":"34","author":"Yamada","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.plipres.2026.101380_bb0635","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.freeradbiomed.2021.09.012","article-title":"Pre-analytical monitoring and protection of oxidizable lipids in human plasma (vitamin E and \u03c9-3 and \u03c9-6 fatty acids): an update for redox-lipidomics methods","volume":"176","author":"Torquato","year":"2021","journal-title":"Free Radic Biol Med"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb0640","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s10620-014-3031-8","article-title":"OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease","volume":"59","author":"Alkhouri","year":"2014","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.plipres.2026.101380_bb0645","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1369\/0022155420946402","article-title":"4-HNE immunohistochemistry and image analysis for detection of lipid peroxidation in human liver samples using vitamin E treatment in NAFLD as a proof of concept","volume":"68","author":"Podszun","year":"2020","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.plipres.2026.101380_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101710","article-title":"Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis","volume":"37","author":"Podszun","year":"2020","journal-title":"Redox Biol"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb0655","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.plipres.2026.101380_bb0660","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.freeradbiomed.2019.04.017","article-title":"LC-MS\/MS assay for the simultaneous determination of tocopherols, polyunsaturated fatty acids and their metabolites in human plasma and serum","volume":"144","author":"Giusepponi","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb0665","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat Genet"},{"issue":"15","key":"10.1016\/j.plipres.2026.101380_bb0670","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3748\/wjg.v24.i15.1601","article-title":"Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity","volume":"24","author":"Pirola","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.plipres.2026.101380_bb0675","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2015.68","article-title":"Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes","volume":"2","author":"Wruck","year":"2015","journal-title":"Sci Data"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0680","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10050930","article-title":"The role of diagnostic biomarkers, omics strategies, and single-cell sequencing for nonalcoholic fatty liver disease in severely obese patients","volume":"10","author":"Wernberg","year":"2021","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0685","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jand.2013.12.001","article-title":"Position of the academy of nutrition and dietetics: nutritional genomics","volume":"114","author":"Camp","year":"2014","journal-title":"J Acad Nutr Diet"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0690","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized nutrition by prediction of glycemic responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb0695","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071534","article-title":"A nutrigenomic approach to non-alcoholic fatty liver disease","volume":"18","author":"Dongiovanni","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054855","article-title":"Fecal metagenomics and metabolomics identifying microbial signatures in non-alcoholic fatty liver disease","volume":"24","author":"Pekkala","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0705","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0710","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in NAFLD and NASH","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.plipres.2026.101380_bb0715","first-page":"1","article-title":"Metabolic and functional interplay between gut microbiota and fat-soluble vitamins","author":"Stacchiotti","year":"2020","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0720","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s41579-019-0256-8","article-title":"Diet-microbiota interactions and personalized nutrition","volume":"17","author":"Kolodziejczyk","year":"2019","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb0725","doi-asserted-by":"crossref","DOI":"10.3390\/nu13114077","article-title":"Impact of genetic polymorphism on response to therapy in non-alcoholic fatty liver disease","volume":"13","author":"Mart\u00ednez-Montoro","year":"2021","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/nu10121919","article-title":"Vitamin E metabolic effects and genetic variants: a challenge for precision nutrition in obesity and associated disturbances","volume":"10","author":"Galm\u00e9s","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0735","doi-asserted-by":"crossref","first-page":"lmaf078","DOI":"10.1093\/labmed\/lmaf078","article-title":"Vitamin D receptor gene variations and their association with cardiometabolic risk and microvascular complications in metabolic dysfunction-associated steatotic liver disease: evidence from a Turkish cohort","volume":"57","author":"Guzel Dirim","year":"2026","journal-title":"Lab Med"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0740","doi-asserted-by":"crossref","DOI":"10.3390\/nu10010029","article-title":"Disturbed vitamin a metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"10","author":"Saeed","year":"2017","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0745","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095366","article-title":"Genetic polymorphism of cytochrome P450 4F2, vitamin E level and histological response in adults and children with nonalcoholic fatty liver disease who participated in PIVENS and TONIC clinical trials","volume":"9","author":"Athinarayanan","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0750","first-page":"634","article-title":"Role of the PNPLA3 polymorphism rs738409 on silymarin + vitamin E response in subjects with non-alcoholic fatty liver disease","volume":"110","author":"Aller","year":"2018","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.plipres.2026.101380_bb0755","doi-asserted-by":"crossref","first-page":"1182037","DOI":"10.3389\/fendo.2023.1182037","article-title":"New anti-diabetic agents for the treatment of non-alcoholic fatty liver disease: a systematic review and network meta-analysis of randomized controlled trials","volume":"14","author":"Kongmalai","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.plipres.2026.101380_bb0760","first-page":"1499","article-title":"The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review","volume":"79","author":"Zachou","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"issue":"21","key":"10.1016\/j.plipres.2026.101380_bb0765","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2174\/1568026623666230714113808","article-title":"Emerging therapies and therapeutic targets for composite liver disease: NASH","volume":"23","author":"Sobhia","year":"2023","journal-title":"Curr Top Med Chem"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0770","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41401-022-00860-3","article-title":"Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis","volume":"43","author":"Yang","year":"2022","journal-title":"Acta Pharmacol Sin"},{"issue":"9","key":"10.1016\/j.plipres.2026.101380_bb0775","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jamainternmed.2019.2248","article-title":"Association of weight loss interventions with changes in biomarkers of nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"179","author":"Koutoukidis","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"3\u20134","key":"10.1016\/j.plipres.2026.101380_bb0780","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00726-003-0048-2","article-title":"Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach","volume":"25","author":"Calabrese","year":"2003","journal-title":"Amino Acids"},{"key":"10.1016\/j.plipres.2026.101380_bb0785","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2013.05.045","article-title":"How do nutritional antioxidants really work: nucleophilic tone and Para-hormesis versus free radical scavenging in vivo","volume":"66","author":"Forman","year":"2014","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb0790","article-title":"Long-term exposure to ambient PM2.5 and its constituents is associated with MAFLD","volume":"5","author":"Guo","year":"2023","journal-title":"JHEP Rep"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0795","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2174\/0113816128295053240207090928","article-title":"The potential of natural products in the management of cardiovascular disease","volume":"30","author":"Singhai","year":"2024","journal-title":"Curr Pharm Des"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0800","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/jpn3.12346","article-title":"Environmental toxicants modulate disease severity in pediatric metabolic dysfunction-associated steatohepatitis","volume":"79","author":"Jain","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0805","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1186\/s12889-025-21930-1","article-title":"Multifaceted environmental factors linked to metabolic dysfunction-associated fatty liver disease: an environment-wide association study","volume":"25","author":"Dong","year":"2025","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0810","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/a-2540-2861","article-title":"Environmental pollutants, occupational exposures, and liver disease","volume":"45","author":"Beier","year":"2025","journal-title":"Semin Liver Dis"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0815","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2023.02.034","article-title":"The exposome and liver disease - how environmental factors affect liver health","volume":"79","author":"Barouki","year":"2023","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0820","doi-asserted-by":"crossref","DOI":"10.3390\/metabo15080528","article-title":"Dietary strategies in the prevention of MASLD: a comprehensive review of dietary patterns against fatty liver","volume":"15","author":"Janota","year":"2025","journal-title":"Metabolites"},{"key":"10.1016\/j.plipres.2026.101380_bb0825","doi-asserted-by":"crossref","first-page":"1667377","DOI":"10.3389\/fnut.2025.1667377","article-title":"Efficacy of non-pharmacological treatments in pediatric MASLD: a review of the literature","volume":"12","author":"Mosca","year":"2025","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0830","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1186\/s12889-024-19378-w","article-title":"Efficacy of the Mediterranean diet in treating metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents: a systematic review and meta-analysis","volume":"24","author":"Jamil","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.plipres.2026.101380_bb0835","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.716783","article-title":"Dietary interventions in patients with non-alcoholic fatty liver disease: a systematic review and Meta-analysis","volume":"8","author":"Houttu","year":"2021","journal-title":"Front Nutr"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb0840","article-title":"The vicious circle of metabolic dysfunction-associated steatotic liver disease when micronutrient deficiency drives microbial imbalance and liver injury","volume":"15","author":"Marginean","year":"2025","journal-title":"Life (Basel)"},{"issue":"9","key":"10.1016\/j.plipres.2026.101380_bb0845","doi-asserted-by":"crossref","DOI":"10.3390\/nu10091153","article-title":"Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence","volume":"10","author":"Cicero","year":"2018","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0850","doi-asserted-by":"crossref","DOI":"10.3390\/nu17101657","article-title":"Nutraceutical strategies for metabolic dysfunction-associated steatotic liver disease (MASLD): a path to liver health","volume":"17","author":"Vrentzos","year":"2025","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.iliver.2024.100131","article-title":"New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products","volume":"3","author":"Yadav","year":"2024","journal-title":"ILIVER"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0915","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12986-024-00830-y","article-title":"The association between vitamin E intake and hepatic steatosis in general and obese populations","volume":"21","author":"Chen","year":"2024","journal-title":"Nutr Metab (Lond)"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb0940","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/apt.18149","article-title":"The effect of vitamin E and docosahexaenoic acid ethyl ester on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-a randomised, double-blind, placebo-controlled, parallel-group clinical trial (PUVENAFLD)","volume":"60","author":"Alkhouri","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"issue":"18","key":"10.1016\/j.plipres.2026.101380_bb0965","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.plipres.2026.101380_bb0970","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0890","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.chembiol.2021.04.019","article-title":"Endogenous vitamin E metabolites mediate allosteric PPAR\u03b3 activation with unprecedented co-regulatory interactions","volume":"28","author":"Willems","year":"2021","journal-title":"Cell Chem Biol"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0935","article-title":"Vitamin E and non-alcoholic fatty liver disease: investigating the evidence through a systematic review","volume":"16","author":"Abera","year":"2024","journal-title":"Cureus"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb0985","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/apt.16583","article-title":"Systematic review with network meta-analysis: comparative efficacy of pharmacologic therapies for fibrosis improvement and resolution of NASH","volume":"54","author":"Majzoub","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb1020","article-title":"Vitamin E (300 mg) in the treatment of MASH: a multi-center, randomized, double-blind, placebo-controlled study","volume":"6","author":"Song","year":"2025","journal-title":"Cell Rep Med"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101491","article-title":"Dietary macro and micronutrients associated with MASLD: analysis of a national US cohort database","volume":"29","author":"Nemer","year":"2024","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb0925","doi-asserted-by":"crossref","first-page":"927","DOI":"10.14309\/ajg.0000000000001726","article-title":"Dietary vitamin E intake is associated with a reduced risk of developing digestive diseases and nonalcoholic fatty liver disease","volume":"117","author":"Scorletti","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0900","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133309","article-title":"Vitamin E sequestration by liver fat in humans","volume":"5","author":"Violet","year":"2020","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb0905","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3945\/ajcn.116.138495","article-title":"Metabolic syndrome increases dietary alpha-tocopherol requirements as assessed using urinary and plasma vitamin E catabolites: a double-blind, crossover clinical trial","volume":"105","author":"Traber","year":"2017","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0945","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1017\/S000711451500272X","article-title":"Vitamin E function and requirements in relation to PUFA","volume":"114","author":"Raederstorff","year":"2015","journal-title":"Br J Nutr"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1170","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1038\/s41598-022-11950-x","article-title":"Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis","volume":"12","author":"Sindhughosa","year":"2022","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1175","doi-asserted-by":"crossref","first-page":"6714","DOI":"10.1038\/s41598-024-57380-9","article-title":"The contribution of vitamin D insufficiency to the onset of steatotic liver disease among individuals with metabolic dysfunction","volume":"14","author":"Lee","year":"2024","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb1180","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.numecd.2006.04.002","article-title":"Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease","volume":"17","author":"Targher","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb1085","doi-asserted-by":"crossref","DOI":"10.3390\/nu12113302","article-title":"Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): an update","volume":"12","author":"Barchetta","year":"2020","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.plipres.2026.101380_bb1200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25094901","article-title":"Vitamin D and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): novel mechanistic insights","volume":"25","author":"Aggeletopoulou","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb1145","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2174\/1389557518666181025153712","article-title":"Association between vitamin D levels and nonalcoholic fatty liver disease: potential confounding variables","volume":"19","author":"Pacifico","year":"2019","journal-title":"Mini-Rev Med Chem"},{"key":"10.1016\/j.plipres.2026.101380_bb1150","doi-asserted-by":"crossref","first-page":"7643542","DOI":"10.1155\/2019\/7643542","article-title":"The level of vitamin D in children and adolescents with nonalcoholic fatty liver disease: a meta-analysis","volume":"2019","author":"Zhu","year":"2019","journal-title":"Biomed Res Int"},{"issue":"12","key":"10.1016\/j.plipres.2026.101380_bb1155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0168216","article-title":"Docosahexanoic acid plus vitamin D treatment improves features of NAFLD in children with serum vitamin D deficiency: results from a single Centre trial","volume":"11","author":"Della Corte","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb1160","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/gutjnl-2014-308175","article-title":"Vitamin D and liver fibrosis: let\u2019s start soon before it\u2019s too late","volume":"64","author":"Nobili","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1190","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/MEG.0000000000002653","article-title":"Steatosis regression assessed by cap after vitamin \u2018D\u2019 supplementation in NAFLD patients with vitamin \u2018D\u2019 deficiency","volume":"36","author":"Emam","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.plipres.2026.101380_bb1195","doi-asserted-by":"crossref","first-page":"1138078","DOI":"10.3389\/fendo.2023.1138078","article-title":"Vitamin D improves hepatic steatosis in NAFLD","volume":"14","author":"Du","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nbu.12369","article-title":"Mobilising vitamin D from adipose tissue: the potential impact of exercise","volume":"44","author":"Hengist","year":"2019","journal-title":"Nutr Bull"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb1230","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/ajcn\/72.3.690","article-title":"Decreased bioavailability of vitamin D in obesity","volume":"72","author":"Wortsman","year":"2000","journal-title":"Am J Clin Nutr"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb1295","doi-asserted-by":"crossref","DOI":"10.3390\/nu12113372","article-title":"Impact of long-term supplementation with fish oil in individuals with non-alcoholic fatty liver disease: a double blind randomized placebo controlled clinical trial","volume":"12","author":"Cansan\u00e7\u00e3o","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.plipres.2026.101380_bb1275","doi-asserted-by":"crossref","first-page":"30029","DOI":"10.1038\/srep30029","article-title":"\u03c9-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP\/TAZ degradation","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.plipres.2026.101380_bb1285","doi-asserted-by":"crossref","first-page":"1192099","DOI":"10.3389\/fpubh.2023.1192099","article-title":"Omega-3 intake is associated with liver disease protection","volume":"11","author":"Vell","year":"2023","journal-title":"Front Public Health"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb1290","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/10408363.2015.1092106","article-title":"Omega-3 fatty acids: mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD","volume":"53","author":"Nobili","year":"2016","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb1265","article-title":"Effectiveness of Omega-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"16","author":"Aziz","year":"2024","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb1335","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000124","article-title":"Low vitamin a levels are associated with liver-related mortality: a nationally representative cohort study","volume":"7","author":"Song","year":"2023","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb1310","doi-asserted-by":"crossref","DOI":"10.3390\/nu13051703","article-title":"Vitamin a update: forms, sources, kinetics, detection, function, deficiency, therapeutic use and toxicity","volume":"13","author":"Carazo","year":"2021","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1360","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/s41598-024-52077-5","article-title":"Association between dietary vitamin a intake from different sources and non-alcoholic fatty liver disease among adults","volume":"14","author":"Liu","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.plipres.2026.101380_bb1430","doi-asserted-by":"crossref","first-page":"1086477","DOI":"10.3389\/fnut.2023.1086477","article-title":"The relationship between vitamin K and metabolic dysfunction-associated fatty liver disease among the United States population: National Health and Nutrition Examination Survey 2017-2018","volume":"10","author":"Wang","year":"2023","journal-title":"Front Nutr"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1440","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1038\/s41598-024-53644-6","article-title":"Vitamin K2 protects mice against non-alcoholic fatty liver disease induced by high-fat diet","volume":"14","author":"Zhao","year":"2024","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb1380","doi-asserted-by":"crossref","DOI":"10.1002\/fsn3.70431","article-title":"Vitamin K: metabolism, genetic influences, and chronic disease outcomes","volume":"13","author":"Dupuy","year":"2025","journal-title":"Food Sci Nutr"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1435","doi-asserted-by":"crossref","first-page":"19272","DOI":"10.1038\/s41598-025-03258-3","article-title":"Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients","volume":"15","author":"Huang","year":"2025","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb1465","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/07315724.2015.1021057","article-title":"Functions of coenzyme Q10 supplementation on liver enzymes, markers of systemic inflammation, and adipokines in patients affected by nonalcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial","volume":"35","author":"Farsi","year":"2016","journal-title":"J Am Coll Nutr"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1470","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12933-024-02326-8","article-title":"Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial","volume":"23","author":"Vrentzos","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.plipres.2026.101380_bb1460","first-page":"9","article-title":"Coenzyme Q","volume":"21","author":"Dludla","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.plipres.2026.101380_bb0860","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.freeradbiomed.2016.09.017","article-title":"Vitamin E: emerging aspects and new directions","volume":"102","author":"Galli","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.plipres.2026.101380_bib1516","article-title":"Dark chocolate fortification with vitamin E and its effect on cocoa epicatechin and total phenolic properties","author":"Bartolini","year":"2026","journal-title":"Preprint"},{"key":"10.1016\/j.plipres.2026.101380_bb0865","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.freeradbiomed.2024.01.024","article-title":"Human Vitamin E deficiency, and what is and is not vitamin E?","volume":"213","author":"Traber","year":"2024","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0870","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1086\/301699","article-title":"Ataxia with isolated vitamin E deficiency: heterogeneity of mutations and phenotypic variability in a large number of families","volume":"62","author":"Cavalier","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb0875","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ng0295-141","article-title":"Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein","volume":"9","author":"Ouahchi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.plipres.2026.101380_bb0880","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.freeradbiomed.2025.04.005","article-title":"Vitamin E nomenclature: summary and response to articles published in the FRBM vitamin E discussion forum","volume":"234","author":"Azzi","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.plipres.2026.101380_bb0885","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0083-6729(07)76009-0","article-title":"Vitamin E biotransformation in humans","volume":"76","author":"Galli","year":"2007","journal-title":"Vitam Horm"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0895","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/antiox7010010","article-title":"Long-chain metabolites of vitamin E: metabolic activation as a general concept for lipid-soluble vitamins?","volume":"7","author":"Schubert","year":"2018","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0910","doi-asserted-by":"crossref","DOI":"10.3390\/diseases6040086","article-title":"The role of vitamin E in the treatment of NAFLD","volume":"6","author":"Perumpail","year":"2018","journal-title":"Diseases"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb0930","article-title":"Vitamin E for people with non-alcoholic fatty liver disease","volume":"10","author":"Wen","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb0950","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0955","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00535-015-1050-7","article-title":"Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"50","author":"Watanabe","year":"2015","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb0960","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","author":"European Association for the Study of the, L., D. European Association for the Study of, and O. European Association for the Study of","year":"2016","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb0975","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/hep.24767","article-title":"The TONIC trial: a step forward in treating pediatric nonalcoholic fatty liver disease","volume":"55","author":"Alkhouri","year":"2012","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb0980","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.485","article-title":"A structured literature review of interventions used in the management of nonalcoholic steatohepatitis (NASH)","volume":"7","author":"Povsic","year":"2019","journal-title":"Pharmacol Res Perspect"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb0990","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1158\/1055-9965.EPI-09-0013","article-title":"Dietary supplement use and prostate cancer risk in the carotene and retinol efficacy trial","volume":"18","author":"Neuhouser","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb0995","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-142-1-200501040-00110","article-title":"Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality","volume":"142","author":"Miller","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.plipres.2026.101380_bb1000","article-title":"The questionable association of vitamin E supplementation and mortality--inconsistent results of different meta-analytic approaches","volume":"55","author":"Gerss","year":"2009","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb1005","article-title":"Scientific opinion on the tolerable upper intake level for vitamin E","volume":"22","author":"Turck","year":"2024","journal-title":"EFSA J"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2003.10.009","article-title":"New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine","volume":"36","author":"Hensley","year":"2004","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb1015","article-title":"Alpha-tocopherol metabolites (the vitamin E metabolome) and their Interindividual variability during supplementation","volume":"10","author":"Bartolini","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.plipres.2026.101380_bb1025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.freeradbiomed.2021.11.012","article-title":"Metabolism of natural forms of vitamin E and biological actions of vitamin E metabolites","volume":"179","author":"Jiang","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.plipres.2026.101380_bb1030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.freeradbiomed.2020.12.017","article-title":"Vitamin E alpha- and gamma-tocopherol mitigate colitis, protect intestinal barrier function and modulate the gut microbiota in mice","volume":"163","author":"Liu","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.plipres.2026.101380_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101166","article-title":"The vitamin E derivative garcinoic acid from Garcinia kola nut seeds attenuates the inflammatory response","volume":"24","author":"Wallert","year":"2019","journal-title":"Redox Biol"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1040","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1038\/s41467-018-06158-5","article-title":"Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenase","volume":"9","author":"Pein","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.plipres.2026.101380_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108884","article-title":"Different forms of vitamin E and metabolite 13'-carboxychromanols inhibit cyclooxygenase-1 and its catalyzed thromboxane in platelets, and tocotrienols and 13'-carboxychromanols are competitive inhibitors of 5-lipoxygenase","volume":"100","author":"Park","year":"2022","journal-title":"J Nutr Biochem"},{"issue":"51","key":"10.1016\/j.plipres.2026.101380_bb1050","doi-asserted-by":"crossref","first-page":"20464","DOI":"10.1073\/pnas.0810962106","article-title":"Long-chain carboxychromanols, metabolites of vitamin E, are potent inhibitors of cyclooxygenases","volume":"105","author":"Jiang","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.plipres.2026.101380_bb1055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2025.05.428","article-title":"Garcinoic acid enhances inflammation resolution against colitis by activating Nrf2 dependent efferocytosis","volume":"237","author":"Isot","year":"2025","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/10715762.2024.2449457","article-title":"Modulation of inflammatory signaling by vitamin E metabolites and its therapeutic implications","volume":"59","author":"Mese-Tayfur","year":"2025","journal-title":"Free Radic Res"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb1065","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1021\/acs.jmedchem.0c00012","article-title":"Garcinoic acid is a natural and selective agonist of pregnane X receptor","volume":"63","author":"Bartolini","year":"2020","journal-title":"J Med Chem"},{"issue":"33","key":"10.1016\/j.plipres.2026.101380_bb1070","doi-asserted-by":"crossref","first-page":"11866","DOI":"10.1074\/jbc.RA120.013303","article-title":"Garcinoic acid prevents \u03b2-amyloid (A\u03b2) deposition in the mouse brain","volume":"295","author":"Marinelli","year":"2020","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4161\/derm.24494","article-title":"Sunlight and vitamin D: a global perspective for health","volume":"5","author":"Wacker","year":"2013","journal-title":"Dermatoendocrinol"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb1080","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1210\/er.2018-00126","article-title":"Skeletal and Extraskeletal actions of vitamin D: current evidence and outstanding questions","volume":"40","author":"Bouillon","year":"2019","journal-title":"Endocr Rev"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb1090","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jhep.2016.05.031","article-title":"Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis","volume":"65","author":"Bozic","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.plipres.2026.101380_bb1095","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102695","article-title":"Vitamin D: a master example of nutrigenomics","volume":"62","author":"Carlberg","year":"2023","journal-title":"Redox Biol"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb1100","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae077","article-title":"Vitamin D receptor regulates liver regeneration after partial hepatectomy in male mice","volume":"165","author":"Elangovan","year":"2024","journal-title":"Endocrinology"},{"key":"10.1016\/j.plipres.2026.101380_bb1105","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/nu14235104","article-title":"Nongenomic activities of vitamin D","volume":"14","author":"\u017bmijewski","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1110","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bbrc.2016.12.139","article-title":"Nongenomic effects of 1\u03b1,25-dihydroxyvitamin D","volume":"483","author":"Hirota","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb1115","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1172\/JCI106093","article-title":"The role of the liver in the metabolism of vitamin D","volume":"48","author":"Ponchon","year":"1969","journal-title":"J Clin Invest"},{"issue":"20","key":"10.1016\/j.plipres.2026.101380_bb1120","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1073\/pnas.0402490101","article-title":"Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase","volume":"101","author":"Cheng","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3\u20135","key":"10.1016\/j.plipres.2026.101380_bb1125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jsbmb.2011.11.012","article-title":"Metabolism of cholesterol, vitamin D3 and 20-hydroxyvitamin D3 incorporated into phospholipid vesicles by human CYP27A1","volume":"129","author":"Tieu","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"39","key":"10.1016\/j.plipres.2026.101380_bb1130","doi-asserted-by":"crossref","first-page":"15650","DOI":"10.1073\/pnas.1315006110","article-title":"CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo","volume":"110","author":"Zhu","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb1135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.1840040215","article-title":"Intestinal calcium absorption and vitamin D status in chronic cholestatic liver disease","volume":"4","author":"Bengoa","year":"1984","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb1140","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jceh.2019.03.001","article-title":"Impact of vitamin D status in chronic liver disease","volume":"9","author":"Khan","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.plipres.2026.101380_bb1165","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2147\/DMSO.S286334","article-title":"The impact of vitamin D in non-alcoholic fatty liver disease: a cross-sectional study in patients with morbid obesity","volume":"14","author":"Borges-Canha","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"16","key":"10.1016\/j.plipres.2026.101380_bb1185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169016","article-title":"Role of vitamin D in liver disease and complications of advanced chronic liver disease","volume":"23","author":"Ravaioli","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.plipres.2026.101380_bb1205","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/ijpvm.IJPVM_499_17","article-title":"Effect of vitamin D on non-alcoholic fatty liver disease: a systematic review of randomized controlled clinical trials","volume":"10","author":"Hariri","year":"2019","journal-title":"Int J Prev Med"},{"issue":"3","key":"10.1016\/j.plipres.2026.101380_bb1210","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.97205","article-title":"Effects of vitamin D supplementation in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"18","author":"Wei","year":"2020","journal-title":"Int J Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb1215","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3945\/jn.117.254292","article-title":"Patients with nonalcoholic fatty liver disease have a low response rate to vitamin D supplementation","volume":"147","author":"Dasarathy","year":"2017","journal-title":"J Nutr"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb1220","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jadohealth.2011.01.011","article-title":"Low vitamin D status among obese adolescents: prevalence and response to treatment","volume":"48","author":"Harel","year":"2011","journal-title":"J Adolesc Health"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb1235","article-title":"Vitamin D supplementation for chronic liver diseases in adults","volume":"8","author":"Bjelakovic","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb1240","article-title":"Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis","volume":"7","author":"Komolafe","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb1245","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1111\/gcb.13295","article-title":"Climate warming is predicted to reduce omega-3, long-chain, polyunsaturated fatty acid production in phytoplankton","volume":"22","author":"Hixson","year":"2016","journal-title":"Glob Chang Biol"},{"key":"10.1016\/j.plipres.2026.101380_bb1250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.plipres.2016.07.002","article-title":"Metabolism and functional effects of plant-derived omega-3 fatty acids in humans","volume":"64","author":"Baker","year":"2016","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.plipres.2026.101380_bb1255","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-food-111317-095850","article-title":"Omega-3 polyunsaturated fatty acids and their health benefits","volume":"9","author":"Shahidi","year":"2018","journal-title":"Annu Rev Food Sci Technol"},{"issue":"10184","key":"10.1016\/j.plipres.2026.101380_bb1260","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/S0140-6736(19)30041-8","article-title":"Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"393","author":"Collaborators","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb1270","doi-asserted-by":"crossref","DOI":"10.3390\/nu11040872","article-title":"Oxidative stress and non-alcoholic fatty liver disease: effects of Omega-3 fatty acid supplementation","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb1280","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202318367","article-title":"Multi-omic network analysis identified betacellulin as a novel target of omega-3 fatty acid attenuation of western diet-induced nonalcoholic steatohepatitis","volume":"15","author":"Padiadpu","year":"2023","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.plipres.2026.101380_bb1300","article-title":"Hepatic unsaturated fatty acids are linked to lower degree of fibrosis in non-alcoholic fatty liver disease","volume":"8","author":"Frid\u00e9n","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb1305","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb1315","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/nu3040385","article-title":"Vitamin a in reproduction and development","volume":"3","author":"Clagett-Dame","year":"2011","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb1320","doi-asserted-by":"crossref","DOI":"10.3390\/nu14061312","article-title":"Mechanisms of feedback regulation of vitamin a metabolism","volume":"14","author":"O\u2019Connor","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1325","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1021\/cr400161b","article-title":"Retinoic acid actions through mammalian nuclear receptors","volume":"114","author":"Huang","year":"2014","journal-title":"Chem Rev"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166085","article-title":"The role of the retinoid receptor, RAR\/RXR heterodimer, in liver physiology","volume":"1867","author":"Li","year":"2021","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1340","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1194\/jlr.M043844","article-title":"Genetic dissection of retinoid esterification and accumulation in the liver and adipose tissue","volume":"55","author":"Wongsiriroj","year":"2014","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb1345","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1872-034X.2010.00646.x","article-title":"Genetic analysis of expression profile involved in retinoid metabolism in non-alcoholic fatty liver disease","volume":"40","author":"Ashla","year":"2010","journal-title":"Hepatol Res"},{"issue":"7049","key":"10.1016\/j.plipres.2026.101380_bb1350","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb1355","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70087","article-title":"Usefulness of retinol-binding protein in predicting mortality in patients with chronic liver disease","volume":"9","author":"Utakata","year":"2025","journal-title":"JGH Open"},{"key":"10.1016\/j.plipres.2026.101380_bb1365","article-title":"Quantitative analysis of dietary vitamin a metabolites in murine ocular and non-ocular tissues using high-performance liquid chromatography","volume":"214","author":"Leung","year":"2024","journal-title":"J Vis Exp"},{"key":"10.1016\/j.plipres.2026.101380_bb1370","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.740435","article-title":"Metabolomic profiles of plasma retinol-associated dyslipidemia in men and women","volume":"8","author":"Wang","year":"2021","journal-title":"Front Nutr"},{"key":"10.1016\/j.plipres.2026.101380_bb1375","doi-asserted-by":"crossref","first-page":"1713726","DOI":"10.3389\/fnut.2025.1713726","article-title":"Habitual natto intake elevates serum MK-7 levels, enhances osteocalcin carboxylation, and supports bone density: a meta-analysis of Japanese evidence","volume":"12","author":"Wen","year":"2025","journal-title":"Front Nutr"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb1385","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1515\/cclm-2016-0783","article-title":"Vitamin K plasma levels determination in human health","volume":"55","author":"Fusaro","year":"2017","journal-title":"Clin Chem Lab Med"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb1390","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3945\/jn.109.118380","article-title":"Adulthood obesity is positively associated with adipose tissue concentrations of vitamin K and inversely associated with circulating indicators of vitamin K status in men and women","volume":"140","author":"Shea","year":"2010","journal-title":"J Nutr"},{"issue":"11","key":"10.1016\/j.plipres.2026.101380_bb1395","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/jbmr.1677","article-title":"Vitamin K, vertebral fractures, vascular calcifications, and mortality: VItamin K Italian (VIKI) dialysis study","volume":"27","author":"Fusaro","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"13","key":"10.1016\/j.plipres.2026.101380_bb1400","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.1073\/pnas.0711119105","article-title":"Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice","volume":"105","author":"Ferron","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb1405","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.tem.2024.02.006","article-title":"Vitamin K-dependent carboxylation in \u03b2-cells and diabetes","volume":"35","author":"Lacombe","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb1410","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF03347093","article-title":"Vitamin K, bone fractures, and vascular calcifications in chronic kidney disease: an important but poorly studied relationship","volume":"34","author":"Fusaro","year":"2010","journal-title":"J Endocrinol Investig"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb1415","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s42255-023-00821-y","article-title":"Diverse biological functions of vitamin K: from coagulation to ferroptosis","volume":"5","author":"Mishima","year":"2023","journal-title":"Nat Metab"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb1420","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1039\/D3FO02915H","article-title":"Reduction of neutral lipid reservoirs, bioconversion and untargeted metabolomics reveal distinct roles for vitamin K isoforms on lipid metabolism","volume":"15","author":"Silva","year":"2024","journal-title":"Food Funct"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb1425","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.molmed.2022.07.002","article-title":"New insights into vitamin K biology with relevance to cancer","volume":"28","author":"Welsh","year":"2022","journal-title":"Trends Mol Med"},{"issue":"5","key":"10.1016\/j.plipres.2026.101380_bb1445","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1042\/BST20160108","article-title":"Understanding and preventing mitochondrial oxidative damage","volume":"44","author":"Murphy","year":"2016","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.plipres.2026.101380_bb1450","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111521","article-title":"Coenzyme Q10 supplementation in aging and disease","volume":"197","author":"Aaseth","year":"2021","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"10.1016\/j.plipres.2026.101380_bb1455","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.mehy.2009.10.031","article-title":"Do statins cause myopathy by lowering vitamin E levels?","volume":"74","author":"Galli","year":"2010","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb1475","doi-asserted-by":"crossref","DOI":"10.3390\/nu17020229","article-title":"Coenzyme Q and Selenium co-supplementation alleviate methionine choline-deficient diet-induced metabolic dysfunction-associated steatohepatitis in mice","volume":"17","author":"Choi","year":"2025","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb1480","article-title":"Silymarin in combination with vitamin C, vitamin E, coenzyme Q10 and selenomethionine to improve liver enzymes and blood lipid profile in NAFLD patients","volume":"56","author":"Curcio","year":"2020","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.plipres.2026.101380_bb1485","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1038\/s41598-018-37209-y","article-title":"Nutritional and lipidomics biomarkers of docosahexaenoic acid-based multivitamin therapy in pediatric NASH","volume":"9","author":"Torquato","year":"2019","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.plipres.2026.101380_bb1490","doi-asserted-by":"crossref","DOI":"10.3390\/metabo15070436","article-title":"Nutri-epigenetic regulation of vitamin D-impact on metabolism and biological functions: narrative review","volume":"15","author":"Kowal\u00f3wka","year":"2025","journal-title":"Metabolites"},{"issue":"8","key":"10.1016\/j.plipres.2026.101380_bb1495","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082986","article-title":"Nutrition and genetics in NAFLD: the perfect binomium","volume":"21","author":"Meroni","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.plipres.2026.101380_bb1500","doi-asserted-by":"crossref","DOI":"10.3390\/nu10101498","article-title":"A review of mushrooms as a potential source of dietary vitamin D","volume":"10","author":"Cardwell","year":"2018","journal-title":"Nutrients"},{"issue":"6562","key":"10.1016\/j.plipres.2026.101380_bb1505","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1126\/science.abi8206","article-title":"Discovery and implications of polygenicity of common diseases","volume":"373","author":"Visscher","year":"2021","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.plipres.2026.101380_bb1510","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejps.2009.01.006","article-title":"Comparison of effects of VDR versus PXR, FXR and GR ligands on the regulation of CYP3A isozymes in rat and human intestine and liver","volume":"37","author":"Khan","year":"2009","journal-title":"Eur J Pharm Sci"},{"issue":"6","key":"10.1016\/j.plipres.2026.101380_bb1515","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1172\/JCI27793","article-title":"Steroid and xenobiotic receptor and vitamin D receptor crosstalk mediates CYP24 expression and drug-induced osteomalacia","volume":"116","author":"Zhou","year":"2006","journal-title":"J Clin Invest"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782726000056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782726000056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:14:06Z","timestamp":1780449246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782726000056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":304,"alternative-id":["S0163782726000056"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2026.101380","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutrigenomics of fat-soluble vitamins and micronutrients in hepatocyte lipotoxicity and MASLD","name":"articletitle","label":"Article Title"},{"value":"Progress in Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plipres.2026.101380","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101380"}}